2-(2,3-Dihydrobenzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

Ethyl 2-(4-fluoro-phenylamino)-4-methyl-thiazole-5-carboxylate, 98.0%, 250mg

5-Cyano-2-[4-butoxycarbonyl-1-(1,4-diazepenyl)]pyridine, 1g

(S)-3,3'-Dibromo-2,2'-dimethoxy-1,1'-binaphthyl>98.0%(GC)200mg

3-Bromo-N,N-dimethylpropan-1-amine hydrobromide, 95.0%, 25g

(S)-2-(5-Amino-2-(((benzyloxy)carbonyl)amino)-5-oxopentanamido)acetic acid, 95.0%, 5g

1-Hydroxy-cyclohexanecarboxylic acid, 95.0%, 5g

5-(tert-Butyl)-1H-benzo[d]imidazole, 95.0%, 100mg

4-Decenoic Acid, 98.0%, 1g

2-Chloro-4,5-difluorobenzenethiol, 5g

1-(3-chloropyridin-2-yl)piperazine dihydrochloride, 95.0%, 5g

4-Bromo-3-cyanopyridine, 95.0%, 250mg

Solution de sulfate de palladium(II) 10 g